Unichem Laboratories zooms on getting EIR from USFDA

27 Nov 2018 Evaluate

Unichem Laboratories is currently trading at Rs. 217.00, up by 14.40 points or 7.11% from its previous closing of Rs. 202.60 on the BSE.

The scrip opened at Rs. 223.00 and has touched a high and low of Rs. 224.55 and Rs. 215.70 respectively. So far 47214 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 382.00 on 08-Jan-2018 and a 52 week low of Rs. 182.00 on 11-Oct-2018.

Last one week high and low of the scrip stood at Rs. 224.55 and Rs. 201.10 respectively. The current market cap of the company is Rs. 1425.96 crore.

The promoters holding in the company stood at 50.67%, while Institutions and Non-Institutions held 10.22% and 39.11% respectively.

Unichem Laboratories has received Establishment Inspection Report (EIR) for the Post Marketing Adverse Drug Experience inspection conducted at Unichem Bhavan, Prabhat Esate in Mumbai by the US Food and Drug Administration (USFDA) from June 25, 2018 to June 29, 2018, indicating closure of inspection.

Unichem Laboratories is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India and several other markets across the world.

Unichem Lab Share Price

700.00 -13.95 (-1.95%)
09-Jan-2025 12:42 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1830.05
Dr. Reddys Lab 1376.90
Cipla 1491.75
Lupin 2269.35
Zydus Lifesciences 1020.80
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.